
PhysioMRI
Manufacturer of MRI machines and other medical devices.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor | €0.0 | round |
investor | €0.0 | round | |
investor investor | €0.0 | round | |
* | €4.0m | Seed | |
Total Funding | 000k |
EUR | 2022 | 2023 |
---|---|---|
Revenues | 0000 | 0000 |
% growth | - | 98 % |
EBITDA | 0000 | 0000 |
Profit | 0000 | 0000 |
% profit margin | (350 %) | (279 %) |
EV | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x |
R&D budget | 0000 | 0000 |
Source: Company filings or news article
Related Content
PhysioMRI Tech S.L. is a medical technology company founded in 2020 by Jon Fatelevich and Alfonso Rios Alonso, and is headquartered in Valencia, Spain. The company is developing a portable, low-cost magnetic resonance imaging (MRI) machine to make diagnostic imaging more accessible. The device utilizes a permanent magnet array and is designed to be significantly lighter and up to 95% cheaper than conventional MRI systems. This approach aims to democratize MRI testing, particularly for sports medicine, small clinics, primary care centers, and in emerging countries where access is limited.
The company's core product is a portable, low-field MRI scanner that does not require a Faraday cage for operation, simplifying installation and use. Key features include its portability, "Plug and Play" capability, and the use of artificial intelligence and advanced algorithms to enhance image quality and reduce scan times. The technology is designed for imaging extremities like arms and legs, providing high-quality diagnostic images for muscles, ligaments, and other soft tissues. PhysioMRI has a device in operation at La Fe Hospital in Valencia for improving neural networks and image processing.
PhysioMRI's business model is centered on a pay-per-use or leasing option rather than selling the machines outright, aiming to reduce costs for healthcare providers. The company plans to share profits from each scan with the clinic. The firm has raised approximately €4 million ($4.29M) in a Series A funding round from investors including CDTI, the Valencian Institute of Finance (IVF), and notable angel investors from the sports and technology sectors, such as former NBA players Luis Scola and Víctor Claver. The company is targeting CE and FDA certification to enter the market, with initial product deliveries estimated for early 2025.
Keywords: portable MRI, low-cost medical devices, diagnostic imaging, medical technology, soft tissue imaging, pay-per-use model, sports medicine, medtech, magnetic resonance, musculoskeletal imaging